NQO1 is a detoxifying reductase, where lack of function in somatic cells is related to increased benzene oncogenesis and inactivating polymorphism has been related to dismal prognosis and predictive of treatment failure in breast cancer [73]. The gene discussed is NQO1; the disease is breast carcinoma.